A Bioequivalence Study of Two Different Dosage Form of Genakumab

Clinical trial NCT06451848 · COMPLETED

Trial details

NCT number: NCT06451848
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gouty Arthritis (GA)

Start date: 2024-06-24
Primary completion: 2024-11-29
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.